Lazarus: The Awakening (2026)
.jpg)
| Theatrical Performance | ||
| Domestic Box Office | n/a | |
| Further financial details... | ||
Synopsis
A vigilante resurrected from death hunts a drug empire in Jackson, clashing with a kingpin, a reporter, and a city consumed by fentanyl. Justice becomes war.
Metrics
Movie Details
| Domestic Releases: | February 20th, 2026 (Limited) by Samuel Goldwyn Films |
| Video Release: | January 30th, 2026 by Samuel Goldwyn |
| Running Time: | 87 minutes |
| Franchise: | Lazarus |
| Plot point: | Drug Cartels, Vigilante |
| Release detail: | Early / Simultaneous Video-on-Demand release |
| Source: | Original Screenplay |
| Genre: | Action |
| Production Method: | Live Action |
| Creative Type: | Super Hero |
| Production/Financing Companies: | Samuel Goldwyn Films |
| Production Countries: | United States |
| Languages: | English |
Full financial estimates for this film, including domestic and international box office, video sales, video rentals, TV and ancillary revenue are available through our research services. For more information, please contact us at research@the-numbers.com.
Synopsis
A vigilante resurrected from death hunts a drug empire in Jackson, clashing with a kingpin, a reporter, and a city consumed by fentanyl. Justice becomes war.
Metrics
Movie Details
| Domestic Releases: | February 20th, 2026 (Limited) by Samuel Goldwyn Films |
| Video Release: | January 30th, 2026 by Samuel Goldwyn |
| Running Time: | 87 minutes |
| Franchise: | Lazarus |
| Plot point: | Drug Cartels, Vigilante |
| Release detail: | Early / Simultaneous Video-on-Demand release |
| Source: | Original Screenplay |
| Genre: | Action |
| Production Method: | Live Action |
| Creative Type: | Super Hero |
| Production/Financing Companies: | Samuel Goldwyn Films |
| Production Countries: | United States |
| Languages: | English |
Full financial estimates for this film, including domestic and international box office, video sales, video rentals, TV and ancillary revenue are available through our research services. For more information, please contact us at research@the-numbers.com.